imatinib mesylate has been researched along with Nephrotic Syndrome in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arsov, B; Boban, L; Juginović, A; Mandac Rogulj, I; Matišić, V; Molnar, V; Primorac, D | 1 |
1 other study(ies) available for imatinib mesylate and Nephrotic Syndrome
| Article | Year |
|---|---|
Dasatinib-induced nephrotic syndrome: a case of phenoconversion.
Topics: Adult; Antineoplastic Agents; Cytochrome P-450 CYP3A; Dasatinib; Female; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Nephrotic Syndrome; Pharmacogenomic Testing; Phenotype; Protein Kinase Inhibitors; Pyrimidines | 2019 |